SDGR

+ Watchlist + Portfolio

Schrodinger, Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $19.85
52-Week Range: $10.95 – $23.02
Market Cap: $1.46B
P/E (TTM): —
EPS (TTM): -0.72
Dividend Yield: —

Advanced Metrics

Price/Book: 4.34
PEG Ratio: —
Return on Equity: -16.17%
Return on Assets: -14.44%
Gross Margin: 56.87%
Operating Margin: -70.55%
Profit Margin: -20.98%
Current Ratio: 2.71
Debt/Equity: 0.33
Total Debt: $108.00M
Free Cash Flow: $-29.16M
Revenue Growth: 7.50%
Earnings Growth: —
Enterprise Value: $1.16B

SDGR Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$180.96M	$216.67M	$207.54M	$255.87M
Cost of Revenue	$79.93M	$75.97M	$75.46M	$113.25M
Gross Profit	$101.02M	$140.69M	$132.08M	$142.61M
Research & Development	$126.37M	$181.77M	$201.78M	$173.14M
Selling, General & Admin	$121.47M	$136.37M	$139.59M	$136.37M
Operating Expenses	$247.84M	$318.14M	$341.38M	$309.51M
Operating Income	-$146.82M	-$177.45M	-$209.30M	-$166.90M
EBITDA	-$142.47M	-$171.90M	-$203.14M	-$160.87M
Pretax Income	-$149.12M	$42.92M	-$185.71M	-$102.33M
Income Tax	$63.00K	$2.20M	$1.41M	$939.00K
Net Income	-$149.19M	$40.72M	-$187.12M	-$103.27M
Diluted EPS	-2.10	0.54	-2.57	-1.41
Diluted Shares	71.17M	74.99M	72.67M	73.44M

SDGR Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$90.47M	$155.31M	$147.33M	$230.52M
Receivables	$69.09M	$89.12M	$255.33M	$104.39M
Current Assets	$533.99M	$567.80M	$634.99M	$519.26M
Total Assets	$688.59M	$802.96M	$823.23M	$726.16M
Current Liabilities	$108.80M	$133.67M	$191.75M	$189.14M
Total Debt	$116.49M	$127.88M	$117.83M	$109.23M
Total Liabilities	$240.68M	$254.40M	$401.78M	$362.11M
Retained Earnings	-$379.14M	-$338.42M	-$525.54M	-$628.81M
Shareholders' Equity	$447.89M	$548.56M	$421.44M	$364.05M
Working Capital	$425.19M	$434.12M	$443.25M	$330.13M

SDGR Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$119.68M	-$136.73M	-$157.37M	$13.90M
Capital Expenditure	-$8.01M	-$13.40M	-$7.31M	-$1.44M
Free Cash Flow	-$127.70M	-$150.14M	-$164.68M	$12.46M
Depreciation & Amortisation	$4.34M	$5.55M	$6.16M	$6.02M
Stock-Based Compensation	$39.63M	$47.84M	$49.90M	$43.00M
Investing Cash Flow	$90.02M	$193.03M	$148.84M	$57.90M
Financing Cash Flow	$2.11M	$9.05M	$10.12M	$2.93M
Net Change in Cash	-$27.55M	$65.35M	$1.59M	$74.73M

SDGR Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$59.55M	$54.76M	$54.32M	$87.23M	$58.59M
Cost of Revenue	$28.43M	$28.60M	$26.29M	$29.94M	$29.04M
Gross Profit	$31.12M	$26.16M	$28.04M	$57.29M	$29.55M
Research & Development	$45.84M	$43.14M	$42.76M	$41.40M	$43.82M
Selling, General & Admin	$36.17M	$35.92M	$31.23M	$33.05M	$34.52M
Operating Expenses	$82.01M	$79.06M	$73.99M	$74.45M	$78.34M
Operating Income	-$50.89M	-$52.90M	-$45.95M	-$17.16M	-$48.79M
EBITDA	-$49.30M	-$51.37M	-$44.48M	-$15.72M	-$47.32M
Pretax Income	-$59.78M	-$42.89M	-$32.63M	$32.97M	-$59.62M
Income Tax	$28.00K	$287.00K	$162.00K	$462.00K	$408.00K
Net Income	-$59.81M	-$43.17M	-$32.80M	$32.51M	-$60.03M
Diluted EPS	-0.82	-0.59	-0.45	—	-0.81
Diluted Shares	73.06M	73.43M	73.61M	—	73.99M

SDGR Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$326.00M	$219.90M	$172.12M	$230.52M	$260.25M
Receivables	$46.32M	$36.78M	$57.40M	$104.39M	$48.18M
Current Assets	$570.94M	$514.00M	$471.72M	$519.26M	$463.96M
Total Assets	$743.03M	$688.24M	$653.66M	$726.16M	$634.19M
Current Liabilities	$165.47M	$155.77M	$145.11M	$189.14M	$169.54M
Total Debt	$116.16M	$114.31M	$111.43M	$109.23M	$106.96M
Total Liabilities	$369.53M	$345.37M	$332.31M	$362.11M	$320.64M
Retained Earnings	-$585.35M	-$628.52M	-$661.32M	-$628.81M	-$688.83M
Shareholders' Equity	$373.50M	$342.87M	$321.35M	$364.05M	$313.55M
Working Capital	$405.47M	$358.23M	$326.61M	$330.13M	$294.42M

SDGR Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	$144.06M	-$52.20M	-$61.87M	-$16.09M	-$14.83M
Capital Expenditure	-$596.00K	-$314.00K	-$491.00K	-$41.00K	-$2.51M
Free Cash Flow	$143.47M	-$52.51M	-$62.36M	-$16.13M	-$17.34M
Depreciation & Amortisation	$1.59M	$1.53M	$1.47M	$1.44M	$1.48M
Stock-Based Compensation	$11.57M	$10.63M	$10.85M	$9.95M	$9.07M
Investing Cash Flow	$30.63M	-$55.60M	$11.46M	$71.41M	$44.60M
Financing Cash Flow	$409.00K	$2.02M	$307.00K	$197.00K	$569.00K
Net Change in Cash	$175.10M	-$105.78M	-$50.11M	$55.51M	$30.33M

Market Snapshot

About

Schrodinger, Inc. is a life sciences software and drug discovery company that develops physics-based computational platforms for drug discovery and materials design. The company platform is used by pharmaceutical and biotechnology companies, as well as academic and government laboratories worldwide.